A Systematic Review of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Engaging an Old Problem With New Solutions.

CONCLUSIONS: Blinatumomab provides a paradigm-shifting treatment option; however, many questions surrounding optimal patient selection, sequencing, and cost-effectiveness remain.
PMID: 33435716 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - January 13, 2021 Category: Drugs & Pharmacology Authors: Halford Z, Coalter C, Gresham V, Brown T Tags: Ann Pharmacother Source Type: research